CDC Stock Overview
Develops, leases, and sells real estate properties in the Philippines. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Cityland Development Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₱0.68 |
| 52 Week High | ₱0.75 |
| 52 Week Low | ₱0.61 |
| Beta | 0.041 |
| 11 Month Change | -1.45% |
| 3 Month Change | -1.45% |
| 1 Year Change | -6.85% |
| 33 Year Change | -9.48% |
| 5 Year Change | -11.67% |
| Change since IPO | -66.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| CDC | PH Real Estate | PH Market | |
|---|---|---|---|
| 7D | -1.4% | 3.5% | 1.5% |
| 1Y | -6.8% | -2.8% | 15.9% |
Return vs Industry: CDC underperformed the PH Real Estate industry which returned -2.8% over the past year.
Return vs Market: CDC underperformed the PH Market which returned 15.9% over the past year.
Price Volatility
| CDC volatility | |
|---|---|
| CDC Average Weekly Movement | 5.3% |
| Real Estate Industry Average Movement | 5.4% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PH Market | 9.9% |
| 10% least volatile stocks in PH Market | 2.9% |
Stable Share Price: CDC has not had significant price volatility in the past 3 months compared to the PH market.
Volatility Over Time: CDC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 175 | Josef Gohoc | www.cityland.info |
Cityland Development Corporation, together with its subsidiaries, develops, leases, and sells real estate properties in the Philippines. It operates through Sales of Real Estate Properties; Lease of Real Estate Properties; and Pension Plan Operations segments. The company develops medium to high-rise offices, and commercial and residential condominiums, as well as parking slots; and residential subdivisions and farmlots.
Cityland Development Corporation Fundamentals Summary
| CDC fundamental statistics | |
|---|---|
| Market cap | ₱3.33b |
| Earnings (TTM) | ₱749.43m |
| Revenue (TTM) | ₱2.24b |
4.5x
P/E Ratio1.5x
P/S RatioIs CDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CDC income statement (TTM) | |
|---|---|
| Revenue | ₱2.24b |
| Cost of Revenue | ₱745.28m |
| Gross Profit | ₱1.50b |
| Other Expenses | ₱748.52m |
| Earnings | ₱749.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 66.78% |
| Net Profit Margin | 33.41% |
| Debt/Equity Ratio | 9.4% |
How did CDC perform over the long term?
See historical performance and comparison